Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus

Alessandro Barbon, Cesare Orlandi, Luca La Via, Luca Caracciolo, Daniela Tardito, Laura Musazzi, Alessandra Mallei, Massimo Gennarelli, Giorgio Racagni, Maurizio Popoli, Sergio Barlati

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background/Aims: Compelling evidence would suggest the involvement of the serotonin 2C receptor in the pathophysiology of affective disorders and in the action of antidepressants. We analyzed the time course of 5-HT2C receptor (5-HTR2C) mRNA expression during antidepressant treatment in the prefrontal/frontal cortex (P/FC) and in the hippocampus (HC) of rats chronically treated with fluoxetine (a selective serotonin reuptake inhibitor) and reboxetine (a selective noradrenaline reuptake inhibitor). We also analyzed the 5-HTR2C RNA-editing levels at the sites called A, B, C, C' and D, which are known to modulate 5-HTR2C receptor function. Results: The expression profile of 5-HTR2C mRNA was modified during treatment with both antidepressants. In particular, we found a general down-regulation of 5-HTR2C mRNA expression in P/FC, which became significant after 3 weeks of treatment with both antidepressants and persisted after a fourth week of drug withdrawal (-46% with fluoxetine, -41% with reboxetine, p <0.05). In HC, however, reboxetine induced significant down-regulation (-56%, p <0.05) of 5-HTR2C mRNA after 3 weeks, while fluoxetine induced threefold up-regulation (p <0.01) by the 2nd and 3rd week, returning to the base level after drug withdrawal of both antidepressants. Moreover, the frequency of 5-HTR2C-edited isoforms showed no significant alterations, although analysis of the RNA-editing level at the single editing sites showed small decreases in the C' and D sites induced by reboxetine in P/FC. Conclusion: Our results suggest that chronic administration of antidepressants in rats slightly modifies the editing levels of 5-HT2C receptor but has considerable influence on its mRNA expression patterns in a way that is area- and time-specific.

Original languageEnglish
Pages (from-to)160-168
Number of pages9
JournalNeuropsychobiology
Volume63
Issue number3
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Receptor, Serotonin, 5-HT2C
Frontal Lobe
Prefrontal Cortex
Antidepressive Agents
Hippocampus
Messenger RNA
Fluoxetine
RNA Editing
Down-Regulation
Serotonin Uptake Inhibitors
Mood Disorders
Pharmaceutical Preparations
Norepinephrine
Protein Isoforms
Up-Regulation
reboxetine

Keywords

  • 5-HTR2C
  • Antidepressants
  • Gene expression
  • Major depressive disorder
  • RNA editing

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuropsychology and Physiological Psychology
  • Biological Psychiatry

Cite this

Barbon, A., Orlandi, C., La Via, L., Caracciolo, L., Tardito, D., Musazzi, L., ... Barlati, S. (2011). Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. Neuropsychobiology, 63(3), 160-168. https://doi.org/10.1159/000321593

Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. / Barbon, Alessandro; Orlandi, Cesare; La Via, Luca; Caracciolo, Luca; Tardito, Daniela; Musazzi, Laura; Mallei, Alessandra; Gennarelli, Massimo; Racagni, Giorgio; Popoli, Maurizio; Barlati, Sergio.

In: Neuropsychobiology, Vol. 63, No. 3, 02.2011, p. 160-168.

Research output: Contribution to journalArticle

Barbon, A, Orlandi, C, La Via, L, Caracciolo, L, Tardito, D, Musazzi, L, Mallei, A, Gennarelli, M, Racagni, G, Popoli, M & Barlati, S 2011, 'Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus', Neuropsychobiology, vol. 63, no. 3, pp. 160-168. https://doi.org/10.1159/000321593
Barbon, Alessandro ; Orlandi, Cesare ; La Via, Luca ; Caracciolo, Luca ; Tardito, Daniela ; Musazzi, Laura ; Mallei, Alessandra ; Gennarelli, Massimo ; Racagni, Giorgio ; Popoli, Maurizio ; Barlati, Sergio. / Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. In: Neuropsychobiology. 2011 ; Vol. 63, No. 3. pp. 160-168.
@article{a1c7b46083134dc0b1ad5eca3f804251,
title = "Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus",
abstract = "Background/Aims: Compelling evidence would suggest the involvement of the serotonin 2C receptor in the pathophysiology of affective disorders and in the action of antidepressants. We analyzed the time course of 5-HT2C receptor (5-HTR2C) mRNA expression during antidepressant treatment in the prefrontal/frontal cortex (P/FC) and in the hippocampus (HC) of rats chronically treated with fluoxetine (a selective serotonin reuptake inhibitor) and reboxetine (a selective noradrenaline reuptake inhibitor). We also analyzed the 5-HTR2C RNA-editing levels at the sites called A, B, C, C' and D, which are known to modulate 5-HTR2C receptor function. Results: The expression profile of 5-HTR2C mRNA was modified during treatment with both antidepressants. In particular, we found a general down-regulation of 5-HTR2C mRNA expression in P/FC, which became significant after 3 weeks of treatment with both antidepressants and persisted after a fourth week of drug withdrawal (-46{\%} with fluoxetine, -41{\%} with reboxetine, p <0.05). In HC, however, reboxetine induced significant down-regulation (-56{\%}, p <0.05) of 5-HTR2C mRNA after 3 weeks, while fluoxetine induced threefold up-regulation (p <0.01) by the 2nd and 3rd week, returning to the base level after drug withdrawal of both antidepressants. Moreover, the frequency of 5-HTR2C-edited isoforms showed no significant alterations, although analysis of the RNA-editing level at the single editing sites showed small decreases in the C' and D sites induced by reboxetine in P/FC. Conclusion: Our results suggest that chronic administration of antidepressants in rats slightly modifies the editing levels of 5-HT2C receptor but has considerable influence on its mRNA expression patterns in a way that is area- and time-specific.",
keywords = "5-HTR2C, Antidepressants, Gene expression, Major depressive disorder, RNA editing",
author = "Alessandro Barbon and Cesare Orlandi and {La Via}, Luca and Luca Caracciolo and Daniela Tardito and Laura Musazzi and Alessandra Mallei and Massimo Gennarelli and Giorgio Racagni and Maurizio Popoli and Sergio Barlati",
year = "2011",
month = "2",
doi = "10.1159/000321593",
language = "English",
volume = "63",
pages = "160--168",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus

AU - Barbon, Alessandro

AU - Orlandi, Cesare

AU - La Via, Luca

AU - Caracciolo, Luca

AU - Tardito, Daniela

AU - Musazzi, Laura

AU - Mallei, Alessandra

AU - Gennarelli, Massimo

AU - Racagni, Giorgio

AU - Popoli, Maurizio

AU - Barlati, Sergio

PY - 2011/2

Y1 - 2011/2

N2 - Background/Aims: Compelling evidence would suggest the involvement of the serotonin 2C receptor in the pathophysiology of affective disorders and in the action of antidepressants. We analyzed the time course of 5-HT2C receptor (5-HTR2C) mRNA expression during antidepressant treatment in the prefrontal/frontal cortex (P/FC) and in the hippocampus (HC) of rats chronically treated with fluoxetine (a selective serotonin reuptake inhibitor) and reboxetine (a selective noradrenaline reuptake inhibitor). We also analyzed the 5-HTR2C RNA-editing levels at the sites called A, B, C, C' and D, which are known to modulate 5-HTR2C receptor function. Results: The expression profile of 5-HTR2C mRNA was modified during treatment with both antidepressants. In particular, we found a general down-regulation of 5-HTR2C mRNA expression in P/FC, which became significant after 3 weeks of treatment with both antidepressants and persisted after a fourth week of drug withdrawal (-46% with fluoxetine, -41% with reboxetine, p <0.05). In HC, however, reboxetine induced significant down-regulation (-56%, p <0.05) of 5-HTR2C mRNA after 3 weeks, while fluoxetine induced threefold up-regulation (p <0.01) by the 2nd and 3rd week, returning to the base level after drug withdrawal of both antidepressants. Moreover, the frequency of 5-HTR2C-edited isoforms showed no significant alterations, although analysis of the RNA-editing level at the single editing sites showed small decreases in the C' and D sites induced by reboxetine in P/FC. Conclusion: Our results suggest that chronic administration of antidepressants in rats slightly modifies the editing levels of 5-HT2C receptor but has considerable influence on its mRNA expression patterns in a way that is area- and time-specific.

AB - Background/Aims: Compelling evidence would suggest the involvement of the serotonin 2C receptor in the pathophysiology of affective disorders and in the action of antidepressants. We analyzed the time course of 5-HT2C receptor (5-HTR2C) mRNA expression during antidepressant treatment in the prefrontal/frontal cortex (P/FC) and in the hippocampus (HC) of rats chronically treated with fluoxetine (a selective serotonin reuptake inhibitor) and reboxetine (a selective noradrenaline reuptake inhibitor). We also analyzed the 5-HTR2C RNA-editing levels at the sites called A, B, C, C' and D, which are known to modulate 5-HTR2C receptor function. Results: The expression profile of 5-HTR2C mRNA was modified during treatment with both antidepressants. In particular, we found a general down-regulation of 5-HTR2C mRNA expression in P/FC, which became significant after 3 weeks of treatment with both antidepressants and persisted after a fourth week of drug withdrawal (-46% with fluoxetine, -41% with reboxetine, p <0.05). In HC, however, reboxetine induced significant down-regulation (-56%, p <0.05) of 5-HTR2C mRNA after 3 weeks, while fluoxetine induced threefold up-regulation (p <0.01) by the 2nd and 3rd week, returning to the base level after drug withdrawal of both antidepressants. Moreover, the frequency of 5-HTR2C-edited isoforms showed no significant alterations, although analysis of the RNA-editing level at the single editing sites showed small decreases in the C' and D sites induced by reboxetine in P/FC. Conclusion: Our results suggest that chronic administration of antidepressants in rats slightly modifies the editing levels of 5-HT2C receptor but has considerable influence on its mRNA expression patterns in a way that is area- and time-specific.

KW - 5-HTR2C

KW - Antidepressants

KW - Gene expression

KW - Major depressive disorder

KW - RNA editing

UR - http://www.scopus.com/inward/record.url?scp=78651229425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651229425&partnerID=8YFLogxK

U2 - 10.1159/000321593

DO - 10.1159/000321593

M3 - Article

C2 - 21228608

AN - SCOPUS:78651229425

VL - 63

SP - 160

EP - 168

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 3

ER -